Lifebit’s Post

What a fantastic day we had at the Genomics England Research Summit yesterday! From great conversations with colleagues, partners, students, and patient participants at our booth, to attending diverse and fascinating talks on the future of genomics - the summit was an incredible opportunity to learn about the latest approaches and challenges in genomics research and medicine while making new connections. We were very proud to co-present two research posters with our amazing research collaborators: Thiloka Ratnaike from University of Cambridge and Tomas Fitzgerald at European Bioinformatics Institute | EMBL-EBI Thank you to the whole team at Genomics England for putting on such an informative and engaging event. Roll on next year! Thorben Seeger Rosie Davies Sangram Keshari Sahu Christina Chatzipantsiou Dr. Maria C. Dunford Pablo Prieto Barja, PhD Simeón Baker Richard Scott Chiara Bacchelli Amanda White #GERS2024 #GenomicsEngland #ResearchSummit #Lifebit #Genomics #Collaboration #Innovation

🚀 Join us today! 🚀 The Lifebit team is delighted to be at the Genomics England Research Summit today at the Business Design Centre in London! 🌟 We're showcasing our latest innovations in supporting secure data access & research at booth 6. Stop by to meet our experts, discuss your challenges, and explore how Lifebit can power your research. Come and say hello to our team and let's advance precision medicine together. #GenomicsEngland #ResearchSummit #Lifebit #Innovation #Genomics #Healthcare

🔬 The latest report from the Public Policy Projects' team calls for significant reforms in approaches to genomic testing in cancer care, highlighting key challenges and solutions. By addressing process and capacity issues, enhancing pathology lab resources, creating a centralised clinical trials database and increasing clinician education and awareness, the report aims to improve patient outcomes and ensure equitable access to genomic testing across the UK. 💊 Despite advancements, disparities in access remain, underscoring the need for a cultural shift in genomic medicine. You can find the full report below 👇

We are pleased to introduce the Lifebit Clinical Portal v2 - our end-to-end solution to enable clinicians to enhance patient care through improved data management, integrated EHR and genomic data and AI to deliver more accurate diagnostics, and personalized treatments for patients. The key features of our Clinical Portal include: ✅ Robust patient management: Integrate patient histories, treatment plans and ongoing care information. ✅ Automated recruitment & consent management: Streamline and track patient consents quickly & securely, facilitating faster approvals for critical tests and treatments. ✅ Criteria-based notifications: Deploy automated alerts that notify healthcare teams immediately when patients meet predetermined diagnostic or therapeutic criteria. ✅ Seamless clinical note integration: Directly integrate and synchronize clinical notes within patients’ EHR systems, maintaining a single, consistent, and comprehensive patient health record. ✅ Pharmacogenomic reporting: Produce individual participant pharmacogenomic reports to guide clinicians for treatment and dosage recommendations. ✅ Comprehensive genomic data analysis: Scrutinize patient-specific genomic data to detect significant genetic variants that could inform therapeutic strategies. ✅ Dynamic variant filtering and therapy recommendations: Deliver precise therapy recommendations, streamlining the clinical decision-making process. The Lifebit Clinical Portal integrates AI & advanced software capabilities with genomic and health data to streamline patient workflows and ensure more efficient & accurate data management. We are supporting healthcare providers across the world to increase diagnostic accuracy and improve individualized patient care, setting new benchmarks in precision medicine. You can learn more about how our platform meets the complex needs of modern medical institutions in our latest blog: https://bit.ly/3zvkfAd #PrecisionMedicine #Genomics #AI #PatientData #Lifebit

The World Economic Forum's 2024 report highlights privacy-preserving technologies as crucial for enabling global data sharing while protecting privacy and sovereignty. Gain more insight into how advancements in synthetic data and homomorphic encryption are transforming health research and AI innovation: https://bit.ly/3L6F8Em #PrivacyTech #AI #HealthResearch #Lifebit

🚀 Lifebit will be exhibiting at the Genomics England Research Summit 2024 on Tuesday July 9th! The event will be a fantastic opportunity to delve into the latest advancements in genomics research and collaborate with some of the leading experts in the field. Through our poster presentations, you can learn our methods for identifying undiagnosed patients using the most recent data from the 100,000 Genomes Project and how Lifebit utilises our CloudOS Platform to lead mtDNA-focused genotype-phenotype approaches for diagnosing rare diseases. We look forward to connecting with you and sharing our insights. See you there! #GERS2024 #RareDisease #Genomics

We are proud to share highlights from the Marie Claire Power Trip 2024, where our CEO, Dr. Maria C. Dunford, participated in an insightful discussion on AI and the future of entrepreneurship. Moderated by Lina Tsaltampasi, President of SEGE - Greek Association of Women Entrepreneurs , Maria joined industry leaders Alessandra Delfini, General Director at L'Oréal Hellas and Athina Pachatouridis, Strategic Sales Leader for Central and Eastern Europe, Amazon Web Services (AWS) Coordination, to discuss how AI integration with human expertise can drive innovation and create new opportunities, especially for women entrepreneurs. Dive into the details in our latest blog 🚀 https://bit.ly/4bEhN7X #AI #WomenInTech #Sustainability #Lifebit

🧠 We are proud to unveil our new white paper titled "Designing Clinical Trials for Optimal Success", offering innovative strategies and best practices to enhance the reliability and impact of clinical research. In this white paper, you will learn about: - Ensuring robust study design with RCTs, observational studies, and adaptive trial designs. - Selecting relevant and diverse patient populations to ensure generalizability. - Identifying appropriate endpoints and outcome measures. - Robust statistical analysis methods, including Bayesian approaches. - The role of real-world data in complementing traditional trial designs. Stay ahead in clinical research and ensure your trials are designed for success. 📖 Access your copy now: https://bit.ly/3WaX1bz #ClinicalTrials #MedicalResearch #ClinicalResearch #WhitePaper #Lifebit

Find out how federated data analysis is boosting genomics research in our blog post! Genomics research is transforming personalised medicine by studying complete DNA. However, accessing relevant genomic data poses challenges due to security, privacy and data volume. The solution? Data federation. Data federation enables secure access without data movement, fostering collaboration worldwide. With billions of gigabytes generated annually, duplication and movement are costly. Federated analysis saves time and money by analysing distributed data in parallel. Researchers can combine genomic data securely, maximising discoveries. From rare diseases to COVID-19 insights, the potential is immense. For more insights: https://bit.ly/3Xnlv2a #GenomicData #Genomics #DataAnalysis #Lifebit